Literature DB >> 22169256

Toxic epidermal necrolysis: review of pathogenesis and management.

Andrew Downey1, Chris Jackson, Nadia Harun, Alan Cooper.   

Abstract

Toxic epidermal necrolysis (TEN) is a severe cutaneous drug reaction with a mortality rate of approximately 30%. The hallmark of TEN is widespread epidermal sloughing due to keratinocyte apoptosis. Multiple genetic associations between TEN and specific ethnic populations have been determined. The pathophysiology of TEN has yet to be fully elucidated; however, current pathogenic models implicate Fas ligand, granulysin, and reactive oxygen species. The value of current therapies, such as intravenous immunoglobulin and corticosteroids, remains under evaluation.
Copyright © 2011 American Academy of Dermatology, Inc. Published by Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22169256     DOI: 10.1016/j.jaad.2011.09.029

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  25 in total

Review 1.  Toxic Epidermal Necrolysis and Steven-Johnson Syndrome: A Comprehensive Review.

Authors:  Olivia A Charlton; Victoria Harris; Kevin Phan; Erin Mewton; Chris Jackson; Alan Cooper
Journal:  Adv Wound Care (New Rochelle)       Date:  2020-01-09       Impact factor: 4.730

Review 2.  Management of the cutaneous adverse effects of antimelanoma therapy.

Authors:  Rose Congwei Liu; Germana Consuegra; Pablo Fernández-Peñas
Journal:  Melanoma Manag       Date:  2017-11-22

Review 3.  In vitro testing for diagnosis of idiosyncratic adverse drug reactions: Implications for pathophysiology.

Authors:  Abdelbaset A Elzagallaai; Michael J Rieder
Journal:  Br J Clin Pharmacol       Date:  2015-06-01       Impact factor: 4.335

4.  Upregulated RIP3 Expression Potentiates MLKL Phosphorylation-Mediated Programmed Necrosis in Toxic Epidermal Necrolysis.

Authors:  Sue Kyung Kim; Woo-Jung Kim; Jung-Ho Yoon; Jae-Hoon Ji; Michael J Morgan; Hyeseong Cho; You Chan Kim; You-Sun Kim
Journal:  J Invest Dermatol       Date:  2015-03-06       Impact factor: 8.551

5.  Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: A Guide for Nurses.

Authors:  Leah M Hanson; Amanda P Bettencourt
Journal:  AACN Adv Crit Care       Date:  2020-09-15

6.  A case of toxic epidermal necrolysis caused by trimethoprim-sulfamethoxazole.

Authors:  Jharendra P Rijal; Tiffany Pompa; Smith Giri; Vijaya Raj Bhatt
Journal:  BMJ Case Rep       Date:  2014-07-09

Review 7.  Idiosyncratic adverse drug reactions: current concepts.

Authors:  Jack Uetrecht; Dean J Naisbitt
Journal:  Pharmacol Rev       Date:  2013-03-08       Impact factor: 25.468

8.  Toxic Epidermal Necrolysis and Graft-versus-Host Reaction: Revisiting a Puzzling Similarity.

Authors:  G E Piérard; T Hermanns-Lê; P Paquet; A F Rousseau; P Delvenne; C Piérard-Franchimont
Journal:  ISRN Dermatol       Date:  2013-06-03

9.  Combination of infliximab and high-dose intravenous immunoglobulin for toxic epidermal necrolysis: successful treatment of an elderly patient.

Authors:  Konstantinos Patmanidis; Anastasios Sidiras; Konstantinos Dolianitis; Dimitrios Simelidis; Christos Solomonidis; Georgios Gaitanis; Ioannis D Bassukas
Journal:  Case Rep Dermatol Med       Date:  2012-10-09

10.  Rapidly developing toxic epidermal necrolysis.

Authors:  Viktoria Oline Barrios Poulsen; Jonas Nielsen; Troels Dirch Poulsen
Journal:  Case Rep Emerg Med       Date:  2013-08-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.